M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., Edwards, P
At the American Diabetes Association's Scientific Sessions, Mass General Brigham researcher Vanita Aroda, MD, presented results from SOLSTICE, a phase 2b randomized, placebo-controlled clinical trial evaluating the oral GLP-1 receptor agonist elecoglipron
The user defines the targeted charge density, LC peak width, and number of data points, while AGC automatically adjusts ion fill times to ensure optimal data acquisition
But you dont need to go to a doctors office
Doctor Before ordering, youll need a valid prescription for your GLP-1 medication, such as Ozempic, Wegovy, Mounjaro, or Rybelsus